Company: TIPT
Filing Date: 2025-10-31
Form Type: DEFM14A
Source: 0001140361-25-039949
Chunk: 370

Company: TIPTREE INC.
Filing Date: 2025-10-31
Form: DEFM14A
Chunk 370
---
 connection with the D&O Insurance;

(iii) Paying Agent . To the Paying Agent, the following amounts:

(A) the Aggregate Closing Purchase Price;

(B) Purchaser’s fifty percent (50%) portion of the Transfer Taxes;

(C) if the holders of Series A Preferred Stock are not entitled to receive the As-Converted Amount in respect of the Series A Liquidation Preference, the Series A Aggregate Liquidation Preference;

(D) the Equityholders’ Representative Expense Amount;

(E) the Leakage Reserve Holdback Amount;

(F) the Change of Control Waiver Fees and Expense Amount; and

<div align='center'>A-27</div>

#### TABLE OF CONTENTS
(G) the Other Change of Control Consent Fees Amount, together with directions for the Paying Agent to make the following disbursements:

(1) the Equityholders’ Representative Expense Amount to the Equityholders’ Representatives to the Equityholders’ Representative Expense Account specified by the Equityholders’ Representatives at least two (2) Business Days prior to Closing;

(2) payment of the Change of Control Waiver Fees and Expenses Amount;

(3) payment of the Other Change of Control Consent Fees Amount;

(4) Transfer Taxes (inclusive of the fifty (50%) portion of such Transfer Taxes borne by the Equityholders as Transaction Expenses) pursuant to final invoices provided to Purchaser at least two (2) Business Days before the Closing;

(5) the other Transaction Expenses to the third parties to which such Transaction Expenses are owed, pursuant to final invoices provided to Purchaser at least two (2) Business Days before the Closing;

(6) in respect of each Company Share, the Per Share Closing Merger Consideration or Series A Liquidation Preference, as applicable, within two (2) Business Days to each Eligible Holder that has properly completed and duly executed and submitted the Stockholder Transmittal Materials (reduced, in the case of each of the Minority Investors, by their Pro Rata Percentage of the Equityholders’ Representative Expense Amount, attributable to such Company Shares); and

(7) in respect of each Company Equity Award, other than the Performance Awards, the Option Closing Merger Consideration or Per Share Closing Merger Consideration, as applicable, to the Surviving Corporation for payment in the next regular payroll to each holder of such Company Equity Awards, other than the Performance Awards, (reduced